Biotechnology News
Cutting edge news about companies engaged in the research and development of new drugs, medical devices and procedures as well as research, books and information on FDA approvals, patents and awards. Biotechnology news highlights the use of biological processes, organisms or systems to manufacture products that improve the quality of life.
e-Healthcare Solutions, Inc. Enters Into Exclusive Representation Agreement with The American Academy of Family Physicians
e-Healthcare Solutions, Inc. and the American Academy of Family Physicians (AAFP) announced today an agreement calling for e-Healthcare Solutions to provide advertising exclusively to the award winning patient-focused health website familydoctor.org. e-Healthcare Solutions will centrally sell and... - September 19, 2007 - e-Healthcare Solutions, Inc.
AnaSpec Introduces Thirty-Two New Catalog Peptides
Today AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced thirty-two (32) new peptides for drug discovery research. - September 16, 2007 - AnaSpec, EGT Group
AnaSpec Introduces Industry’s First ACE2 Activity Assay Kit
With its reported relation to cardiovascular disease, kidney disease, and severe acute respiratory syndrome (SARS), Angiotensin I converting enzyme 2 (ACE2) has become an increasingly important therapeutic target. - September 12, 2007 - AnaSpec, EGT Group
AnaSpec Introduces New Kinase Peptide Library
AnaSpec, the key supplier of kinase peptide libraries mentioned in the articles, has announced the worldwide commercial availability of its newest kinase peptide library. - September 07, 2007 - AnaSpec, EGT Group
AnaSpec Introduces Fifty-Five New Catalog Peptides
Today AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced fifty-five (55) new peptides for drug discovery research. - September 05, 2007 - AnaSpec, EGT Group
BioWest 2007 Organizers Seek the Best and Brightest of the Rocky Mountain Region’s Bioscience Start-Ups for the Venture Showcase Competition
BioWest, The Rocky Mountain Region’s Premier Bioscience Conference and Expo, is again looking for the best bioscience start-ups in the region as candidates for the $10,000 Faegre & Benson Venture Showcase Award. Six companies will be chosen to present at the Showcase in December, which will be judged by a panel of national venture capitalists. Deadline for entry is September 28, 2007. - August 30, 2007 - Colorado BioScience Association
New Labeled Antibodies: Anti-CD-3ε, Anti-CD79α
Leveraging its expertise in both detection reagents and antibodies, AnaSpec has introduced a new series of labeled Anti-CD-3ε and anti-CD79α antibodies. - August 29, 2007 - AnaSpec, EGT Group
AnaSpec Introduces Thirty-Six New Catalog Peptides
Today AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced thirty-six (36) new peptides for drug discovery research. Protease-Activated Receptor-4; PAR-4 Agonist; amide; human Amyloid Precursor Protein (APP) (667-676); Swedish mutation Colivelin AGA-(C8R)... - August 28, 2007 - AnaSpec, EGT Group
AnaSpec Introduces Industry’s Longest Wavelength Assay Kit for TACE Detection
This week AnaSpec introduced the SensoLyteTM 520 TACE Assay Kit, offering fluorescence detection at the industry’s longest wavelengths. With higher fluorescence quantum yield and longer emission wavelength, this kit shows less autofluorescence interference from test compounds and cellular... - August 28, 2007 - AnaSpec, EGT Group
AnaSpec’s Published References Passes 500
As compiled by Stanford University’s Highwire Press, the number of published papers that cite AnaSpec’s products has passed 500. - August 26, 2007 - AnaSpec, EGT Group
AnaSpec Introduces 10 New Catalog Antibodies
Continuing in its commitment to rapidly expand its antibody offerings, AnaSpec, a leading provider of integrated proteomics solutions, added ten (10) new antibodies to its growing collection of catalog antibodies. Anti-MAP1-LC3 beta (NT) - Cat# 29783, 50 µg Host:rabbit polyclonal; Species... - August 25, 2007 - AnaSpec, EGT Group
AnaSpec Introduces CEF Control Peptide Pool
One of the world’s largest providers of catalog peptides, AnaSpec introduced its CEF Control Peptide Pool. Previously available only individually, this group of peptides is now available pooled. The CEF Control Peptide Pool is a group of 32 peptides, 8-12 amino acids in length, with... - August 23, 2007 - AnaSpec, EGT Group
AnaSpec Introduces 28 New Catalog Antibodies
Continuing in its commitment to rapidly expand its antibody offerings, AnaSpec, a leading provider of integrated proteomics solutions, added twenty-eight (28) new antibodies to its growing collection of catalog antibodies. - August 22, 2007 - AnaSpec, EGT Group
Sleep Study Suggests Magnetic Sleep Machine Promotes Deeper Sleep and Reduces Fibromyalgia Pain
Somnogram shows Sleep on Command™ Delta-rhythm magnetic signals help promote slow-wave, Delta-stage sleep throughout the night resulting in remarkable daytime pain relief in subject with fibromyalgia pain. - August 20, 2007 - EarthPulse Tech, LLC
AnaSpec Introduces New 2007-2009 Combinatorial Chemistry Catalog
One of the world’s largest providers of unusual amino acids, today AnaSpec announced the release of its 2007-2009 Combinatorial Chemistry catalog. - August 18, 2007 - AnaSpec, EGT Group
Why is a TV News Anchor Answering the Absolutely PR Phone?
Denver public relations consulting firm, Absolutely Public Relations, seems to have a new receptionist answering the phone. ut, one moment please, is that a new employee? No, it’s CBS4 Anchor Jim Benemann making good on a silent auction prize he donated to the Denver Press Club (DPC) for the 2007 Damon Runyon event in June. It’s all in fun and all for a very good cause at the Denver Press Club. - August 16, 2007 - Absolutely Public Relations
Analytical Results Highlight Efficacy of AnaSpec MOG Peptides
Reporting on results gathered from its antibody and assay kit departments, AnaSpec has released data that supports the efficacy of its MOG(35-55) peptide. Analytical results reported the following: AnaSpec’s mouse/rat MOG(35-55) peptide induced EAE in C57BL/6 mice with 100% incident (10/10). - July 28, 2007 - AnaSpec, EGT Group
AnaSpec Introduces Acetylated and Methylated Lysines
AnaSpec has introduced acetylated, mono-methylated, di-methylated and tri-methylated Lysine for the synthesis of histone peptides. The use of these building blocks, although not limited to making synthetic histone peptides, provides additional tools for researchers to help unravel the... - July 28, 2007 - AnaSpec, EGT Group
ZYTO Corp. Strategic Alliance with BioNativus Improves Sales for Both Companies
ZYTO Corp. has announced that a marketing agreement with BioNativus for the sale of ZYTO technology to the health care practitioners who are customers of BioNativus has paid off in higher sales for both companies. - July 27, 2007 - Zyto Corp.
AnaSpec Introduces Fourteen New Catalog Peptides
Today AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced fourteen (14) new peptides for drug discovery research. HIV Nef (68–76) - Cat# 61673 This HIV nef peptide 68 to 76 amino acids was identified in HIV-infected individuals. It is a B7... - July 27, 2007 - AnaSpec, EGT Group
AnaSpec Introduces 12 New Catalog Antibodies
Continuing in its commitment to rapidly expand its antibody offerings, AnaSpec, a leading provider of integrated proteomics solutions, added twelve (12) new antibodies to its growing collection of catalog antibodies. The targeted research area for these antibodies is signal transduction and matrix... - July 26, 2007 - AnaSpec, EGT Group
AnaSpec Introduces Ten New Catalog Peptides
Today AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced ten (10) new peptides for drug discovery research. MUC4 - Cat# 61339 This peptide is derived from the tandem repeat of Muc 4 mucin protein. Mucins are highly O-glycosylated proteins which... - July 25, 2007 - AnaSpec, EGT Group
AnaSpec Introduces Eleven New Catalog Peptides
This week AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced eleven (11) new peptides for drug discovery research. - July 22, 2007 - AnaSpec, EGT Group
AnaSpec Introduces New Selection of Cathelicidin Peptides
Cathelicidins are cationic peptides that have broad-range antimicrobial activity. These peptides belong to the family of anti-microbial peptides which form part of the host’s important innate immunity mechanism. - July 20, 2007 - AnaSpec, EGT Group
AnaSpec Introduces Anti-MMP-1 & Anti-MMP-13 (Hinge) Antibodies
AnaSpec has introduced its newest antibody solutions – anti-MMP-1 (Hinge) and anti-MMP-13 (Hinge) antibodies. Strategically raised against the hinge regions of MMP-1 and MMP-13, the epitopes do not overlap the catalytic domain and will not influence the activity of the MMP ferment in... - July 19, 2007 - AnaSpec, EGT Group
American Peptide Symposium Poster Describes Synthesis of Hydrocarbon-Stapled Peptides
At the 2007 annual conference of the American Peptide Society, AnaSpec presented a technical poster that described the facile synthesis of a hydrocarbon-stapled peptide. Asymmetric synthesis of (S)-Fmoc-α-(2’-pentenyl)-alanine was successfully accomplished via an Ala-Ni (II)-BPB-complex... - July 14, 2007 - AnaSpec, EGT Group
AnaSpec Presents Late-Breaking In Vivo Imaging Poster at American Peptide Symposium
At the 2007 annual conference of the American Peptide Society, AnaSpec presented a “late-breaking” technical poster that described in vivo imaging using a tissue-specific near infrared fluorescent peptide conjugate. Extracellular matrix proteins that contain the Arg-Gly-Asp (RGD)... - July 13, 2007 - AnaSpec, EGT Group
PharmaChem Publishes AnaSpec Article on Peptides as Antigens
The June issue of PharmaChem, an Italian journal covering the drug discovery industry, featured an article written by AnaSpec called “Peptides as Antigens.” The technical article, written by Dr. Daniel Li and Cecilia Po, outlines the advantages and methodologies behind using peptides as... - June 24, 2007 - AnaSpec, EGT Group
Embarc Deploys New Online Presence for Athena Diagnostics
A compelling design with robust search features allows Athena to stay ahead of the competition. - June 23, 2007 - Embarc, Inc.
AnaSpec Introduces New SensoLyte™ Beta-Secretase Assay Kit
Leveraging one of the world’s largest collections of amyloid peptides, AnaSpec has introduced its latest development in novel solutions for amyloid-related research - the new SensoLyte™ 520 Beta-Secretase Assay Kit. Beta-secretase catalyzes a key step in the production of beta-amyloid... - June 22, 2007 - AnaSpec, EGT Group
Bio-Synthesis Unveils Online Software ‘Peptide, Oligo, Protein Analysis’
Bio-Synthesis joined with Protein Lounge to bring all the vital and necessary databases to one place. Users have access to the Protein Database, Peptide Antigen Database, and the siRNA database. - June 21, 2007 - Bio-Synthesis Inc.
AnaSpec Introduces Industry’s First and Only Anti-MOG ELISA Kits
Drawing on its broad portfolio of MOG (35-55) and other multiple sclerosis (MS) experimental autoimmune encephalomyelitis (EAE)-related peptides, AnaSpec has just released its new line of SensoLyte™ Anti - MOG ELISA Kits - the industry’s first and only anti-MOG ELISA kits. Myelin... - June 16, 2007 - AnaSpec, EGT Group
AnaSpec Prepares Technical Poster about Beta-Secretase Assay for Experimental Biology 2007
At the 2007 Experimental Biology conference in Washington, DC, AnaSpec prepared a technical poster entitled, "A Sensitive Fluorimetric Assay for Detection of beta-Secretase Activity Using a Novel FRET Peptide Substrate." The poster documented the following findings: • A highly... - June 08, 2007 - AnaSpec, EGT Group
Functional Genetics, Inc. Receives Award to Discover New Opportunities to Combat HIV Infection
Functional Genetics, Inc. Announces a New Award from the National Institute of Allergy and Infectious Diseases to Utilize Its Core Random Homozygous Gene Perturbation and Host-Oriented Therapeutics Technologies to Identify and Validate New Therapeutic Approaches to Combat HIV Infection - June 03, 2007 - Functional Genetics, Inc.
Bio-Synthesis Releases Updated Description for Peptide Synthesis
Peptides are complex molecules and each peptide sequence is unique with regard to its chemical and physical properties. Peptides are synthesized by the solid-phase method using Fmoc chemistry on an Omega 396 multiple peptide synthesizer from Advanced ChemTech. - June 01, 2007 - Bio-Synthesis Inc.
The Imminent Change of the Antithrombotics Market
The antithrombotics market with the two blockbusters enoxaparin and prasugrel is challenged by generic products as well as by next generation anticoagulants with oral administration and antithrombotics with an improved risk-benefit ratio - June 01, 2007 - La Merie Business Intelligence
ZYTO Corp. Announces Activity in Pursuit of NASDAQ Stock Listing
ZYTO Corp. is pursuing a course to list company stock on NASDAQ. The company currently trades in the pink sheets. - May 31, 2007 - Zyto Corp.
Novel Agent for Reactive Metabolite Detection
Bioactivation of drug candidates resulting in chemically reactive, electrophilic metabolites have always presented a major challenge to pharmaceutical companies. Moreover, the measurement of these metabolites has been hampered by the lack of an effective quantitative method. QA-GSH is a novel new... - May 31, 2007 - AnaSpec, EGT Group
Colorado BioScience Association Applauds Governor Ritter’s Signing of HB 1060 As Critical To Future Growth of The State’s Bioscience Industry
Colorado Governor Bill Ritter signed House Bill 1060 into law Wednesday afternoon, with the bill sponsors present to acknowledge the importance of the legislation to the bioscience industry in Colorado. Rep. Jim Riesberg (D-Weld) and Sen. Brandon Shaffer (D-Longmont) were thanked for their efforts... - May 25, 2007 - Colorado BioScience Association
Securing Opportunities in Asia’s Biotech Industry
DN Venture Partners is organising the Asia Biotech Business Mission 2007, from 5th to 9th November 2007, with the aim to help companies and investors understand and capture opportunities in the biotech industry in Asia. - May 23, 2007 - DN Venture Partners Pte Ltd
AnaSpec Introduces Line of Insulin Receptor Antibodies
The insulin receptor is a transmembrane receptor that belongs to the tyrosine kinase receptors class. It is a heterotetrameric glycoprotein composed of disulfide-linked subunits in a β-α-α-β configuration. This transmembrane receptor consists of 95kDa β-subunit, a single... - May 23, 2007 - AnaSpec, EGT Group
Colorado BioScience Association Names Jack Wheeler Chairperson, Announces 2007 Sponsors and Appoints Eight New Board Members
Jack Wheeler, CEO of MicroPhage, Inc., Longmont, is the new chairperson of the board of directors for the Colorado BioScience Association (CBSA). He was appointed at the association’s 2007 annual meeting April 24th. Wheeler assumes chairperson responsibilities from Ed Wood, ArcScan, Inc. In other action, eight new board members were appointed to three-year terms. - May 18, 2007 - Colorado BioScience Association
Industry’s First West Nile Virus Protease Assay Kits
While West Nile virus (WNV) has had significant outbreaks throughout the world since it was first identified, commercially available assay kits for the detection of WNV protease inhibitors had not been developed until now. With the SensoLyte™ series of WNV Protease Assay Kits AnaSpec, a... - May 17, 2007 - AnaSpec, EGT Group
Azani Medical Spa Introduces NeoStem's Adult Stem Cell Collection and Banking Services to Eastern PA and Western NJ
Azani Medical Spa, located in Bethlhem Pennsylvania under the direction of founder and Medical Director Monica Carezani-Gavin, MD, has announced an agreement with the New York City-based biotechnology services company NeoStem, Inc. to become the first facility in Eastern Pennsylvania and Western New Jersey to offer adult stem cell collection and long-term storage services to the public. Individuals interested in more information about these services should visit www.NeoStem.com or call 1-888-STEM-BANK (783-6226). - May 16, 2007 - Azani Medical Spa
2007-08 Bioscience Colorado Magazine Debuts at BIO International Convention in Boston
Colorado Bioscience Association is releasing the new edition of Bioscience Colorado Magazine at the 2007 BIO International Convention, May 6-9, at the Boston Convention & Exhibition Center. This year’s magazine has expanded to 80 pages and includes an updated directory of the Colorado Bioscience industry: Medical Device and Related Companies; Biotechnology, Pharmaceutical and Related Companies; Biofuels and Related Companies; Research & Education Institutions; Foundations; & Service Providers. - May 06, 2007 - Colorado BioScience Association
Artificial Sun for Cell Culture Heating
The LAMBDA MINIFOR fermenter / bioreactor provides a new heating system for precise, fast and economic heating of the culture medium in fermentation and cell culture processes - April 29, 2007 - LAMBDA Laboratory Instruments
Website Re-Design Helps Ensure Nobel Pauling Biotech Symposium
Pauling Biotech Symposium gets ready with a new logo and web design from LogoBee.com - April 26, 2007 - LogoBee Logo Design
Interleukin & Chemokine Antibodies – Two Types of Cytokine Antibodies
Interleukin-32 (IL-32), whose expression is increased following activation by IL-2, was initially identified as a transcript (NK4) selectively expressed in lymphocytes and NK cells.1 - April 18, 2007 - AnaSpec, EGT Group
Zyto Corp. Announces Additional Presenter at Biotechnology Conference for Healthcare Practitioners
Zyto Corp. (OTC - ZYTC.pk) has announced the addition of Dr. Jeff Wheelwright, DC, as a presenter at a three-day conference in Park City, Utah offered at no charge to healthcare professionals. - April 18, 2007 - Zyto Corp.
ZYTO Corp. Announces Bio-technology Conference to Include Anti-aging Presentation
ZYTO Corp. (OTC - ZYTC.pk) has announced that Dr. Paul Ling Tai will address the healthcare practitioners at the annual ZYTO Conference on the subject of natural bio-phyto hormones for the ultimate anti-aging program. - April 13, 2007 - Zyto Corp.